Skip to content

Study on the Effects and Mechanisms of Cerebellar-M1 Dual-Target Intermittent Theta Burst Stimulation Combined with Augmented Reality Gait Adaptability Training on Gait Function and Brain Functional Connectivity in Stroke Patients

Study on the Effects and Mechanisms of Cerebellar-M1 Dual-Target Intermittent Theta Burst Stimulation Combined with Augmented Reality Gait Adaptability Training on Gait Function and Brain Functional Connectivity in Stroke Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108576
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-02
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

M1 single-target iTBS stimulation walking group:M1 intermittent transcranial magnetic stimulation
Double - target stimulation walking group:Cerebellar and M1 dual-target iTBS

Sponsors

Zhejiang Rehabilitation Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stroke (symptoms and signs, imaging indicators, etc.); The diagnosis of cerebral hemorrhage is based on the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage 2019, and the diagnosis of ischemic stroke is based on the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018. 2. Age 18~75 years old, first onset, disease duration 2-12 months, stable and no progress; 3. Unilateral limb hemiplegia, lower limb Brunnstrom motor function grade III.-V.; 4. Concise mental state screening scale illiteracy >=17 points, primary school >=20 points, middle school >=24 points; 5. Standing balance level 2 or above; 6. Be able to walk independently for more than 30 meters; 7. Patients can tolerate transcranial magnetic stimulation; 8. Patients or legal guardians agree and sign the informed consent form. Note: Those who meet all the above 8 items will be enrolled.

Exclusion criteria

Exclusion criteria: 1. Those who are accompanied by severe cognitive impairment and speech impairment and cannot cooperate with the training; 2. Hemianopia and visual impairment; 3. Vestibular dysfunction such as vertigo and tinnitus; 4. Those who are unable to train with lower limb fractures, severe bone and joint diseases, and severe cardiovascular and lung liver and kidney diseases; 5. Those with orthostatic hypotension; 6. Those with a history of epilepsy, metal pacemakers in the body, metal implants in the brain, and skull defects that are not suitable for transcranial magnetic stimulation therapy or evaluation; 7. Those who are expected to not be able to complete the trial and may not have good compliance.

Design outcomes

Primary

MeasureTime frame
Quantitative electroencephalogram;Near-infrared spectroscopy imaging technology;Surface Electromyography;

Secondary

MeasureTime frame
Three - dimensional gait;

Countries

China

Contacts

Public ContactLinjie Fang

Zhejiang Rehabilitation Medical Center

3478397542@qq.com+86 187 6716 7815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026